Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care-Reference-Cited by-同舟云学术

Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care

Published:2020-01-01 Issue:1 Volume:6 Page:84
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Penson Alexander¹²³,Camacho Niedzica¹²⁴,Zheng Youyun²⁴,Varghese Anna M.⁵,Al-Ahmadie Hikmat⁴,Razavi Pedram⁵,Chandarlapaty Sarat¹⁵,Vallejo Christina E.⁴,Vakiani Efsevia²⁴,Gilewski Teresa⁵,Rosenberg Jonathan E.⁵,Shady Maha²⁴,Tsui Dana W. Y.²⁴,Reales Dalicia N.⁶,Abeshouse Adam¹²³,Syed Aijazuddin⁴,Zehir Ahmet⁴,Schultz Nikolaus¹²³,Ladanyi Marc¹⁴,Solit David B.¹²⁵⁷,Klimstra David S.⁴⁸,Hyman David M.⁵⁷,Taylor Barry S.¹²³,Berger Michael F.¹²⁴⁸

Affiliation:

1. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York

2. Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York

3. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

4. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York

5. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

6. Clinical Research Administration, Memorial Sloan Kettering Cancer Center, New York, New York

7. Weill Cornell Medical College, Department of Medicine, Cornell University, New York, New York

8. Weill Cornell Medical College, Department of Pathology and Laboratory Medicine, Cornell University, New York, New York

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2755639/jamaoncology_penson_2019_oi_190081.pdf

Reference30 articles.

1. Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 mutations.;Hyman;N Engl J Med,2015

2. Clinical and molecular characterization of patients with cancer of unknown primary in the modern era.;Varghese;Ann Oncol,2017

3. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.;Golub;Science,1999

4. Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction.;Greco;Oncologist,2010

5. TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen.;Marquard;BMC Med Genomics,2015

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Image-based deep learning model using DNA methylation data predicts the origin of cancer of unknown primary;Neoplasia;2024-09

2. Artificial intelligence for the colorectal surgeon in 2024 – A narrative review of Prevalence, Policies, and (needed) Protections;Seminars in Colon and Rectal Surgery;2024-09

3. Seeing the primary tumor because of all the trees: Cancer type prediction on low-dimensional data;Frontiers in Medicine;2024-08-27

4. Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC;Hepatology;2024-06-19

5. The evolution of molecular management of carcinoma of unknown primary;Current Opinion in Oncology;2024-06-17